Author = Thanh Ha Vu
Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study

Volume 25, Issue 10, October 2024, Pages 3567-3576

Tu Anh Do; Hoa Thi Thai Nguyen; Phuong Cam Pham; Khoi Tuan Nguyen; Thu Thi Anh Hoang; Anh Tuan Le; Hao Dinh Thy Vuong; Tam Dac Nhan Nguyen; Khiem Van Dang; Oanh Thi Nguyen; Luan Van Pham; Hai Minh Nguyen; Trang Thi Huyen Vo; Do Hung Kien; Thanh Ha Vu; Hang Thi Thuy Nguyen; Thai Van Pham; Huy Le Trinh; Gia Hoang Nguyen; Minh Cong Truong; Chau Tran Minh Pham; Phuong Thi Bich Nguyen


Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung Cancer in Vietnam

Volume 22, Issue 5, May 2021, Pages 1581-1590

Thanh Ha Vu; Hoa Thi Thai Nguyen; Linh Khanh Dao; Chi Khanh Duong; Cao Van Nguyen; Tuyet Thi Doan; Hang Thi Thuy Nguyen; Hung Huy Hoang; Dung Khac Dinh; Giang Vinh Le; Thanh Thi Vu; Minh Cong Truong; Long Thanh Nguyen


Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam

Volume 22, Issue 3, March 2021, Pages 853-859

Huyen Thi Phung; Minh Cong Truong; Long Thanh Nguyen; Anh Thi Van Dang; Thanh Ha Vu; Hoa Thi Nguyen